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Extracts from natural products, especially microorganisms, have served as a valuable source of diverse 
molecules in many drug discovery efforts and led to the discovery of several important drugs. Identification 
of microbial strains having promising biological activities and purifying the bio-molecules responsible for 
the activities, have led to the discovery of many bioactive molecules. Extracellular, as well as intracellular, 
extracts of the metabolites of thirty-six bacterial and twenty-four fungal isolates, grown under unusual 
conditions such as high temperature, high salt and low sugar concentrations, were in vitro tested for 
their cytotoxic potential on various cancer cell lines. The extracts were screened on HeLa and MCF-7 
cell lines to study the cytotoxic potential. Nuclear staining and flow cytometric studies were carried 
out to assess the potential of the extracts in arresting the cell cycle. The crude ethylacetate extract of 
isolate F-21 showed promising results by MTT assay with IC50 as low as 20.37±0.36 μg/mL on HeLa, 
and 44.75±0.81 μg/mL on MCF-7 cells, comparable with Cisplatin. The isolate F-21 was identified as 
Aspergillus sp. Promising results were also obtained with B-2C and B-4E strains. Morphological studies, 
biochemical tests and preliminary chemical investigation of the extracts were also carried out. 
Uniterms: Anticancer. Cytotoxicity. Flow cytometry. Microbial extracts. MTT assay.
Extratos de produtos naturais, especialmente de microrganismos, constituíram-se em fonte valiosa de 
diversas moléculas em muitas descobertas de fármacos e levaram à descoberta de fármacos importantes.  A 
identificação de espécies microbianas que apresentam atividade biológica e a purificação de biomoléculas 
responsáveis pelas atividades levou à descoberta de muitas moléculas bioativas. Extratos extracelulares 
tanto quanto intracelulares de metabólitos de 36 isolados de bactérias e 24 isolados de fungos, que 
cresceram sob condições não usuais, como alta temperatura, alta concentração de sal e baixa concentração 
de açúcar, foram testados in vitro quanto ao seu potencial citotóxico em várias linhagens de câncer.   Os 
extratos foram ensaiados em células HeLa e MCF-7 para o estudo do potencial citotóxico. A coloração 
nuclear e os estudos de citometria de fluxo foram realizados para avaliar o potencial dos extratos em 
bloquear o ciclo celular. O extrato bruto em acetato de etila do isolado F-21 mostrou resultados promissores 
no ensaio de MTT, com IC50 de 20,37±0,36 μg/mL em células HeLa e 44,.75±0,81 μg/mL em células 
MCF-7, comparativamente à cisplatina. O isolado F-21 foi identificado como Aspergillus sp.  Resultados 
promissores foram obtidos com cepas B-2C e B-4E. Realizaram-se, também, estudos morfológicos, 
testes bioquímicos e investigação química preliminar dos extratos.  
Unitermos: Anticâncer. Citotoxicidade. Citometria de fluxo. Extratos microbianos. Ensaios MTT.
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INTRODUCTION
From time immemorial, natural products have 
played an important role in treating and preventing human 
diseases. Natural products with medicinal value have come 
from various sources viz., terrestrial plants, terrestrial 
microorganisms, marine organisms, and terrestrial ver-
tebrates and invertebrates (Newman et al., 2000, 2002).
The microbial extracts have served as a valuable source 
of diverse molecules in many drug discovery efforts and 
led to the isolation of several important drugs. Microbial 
diversity contributes as an infinite resource for novel drug 
discovery. Recent estimates suggest that to date, we only 
know approximately 5% of the total species of fungi and 
maybe as little as 0.1 % of bacteria. And among the those 
already described, only a small fraction has been examined 
for their biological activity profile (Clardy, 2007). Pharma-
cological evaluation of microbial extracts is an essential 
aspect of the drug discovery process. Developments in 
the area of in vitro techniques have substantially trans-
formed this facet of natural product chemistry (Rahman 
et al., 2001). The microbial secondary metabolites can 
be brought into use in three different ways: the bioactive 
molecule can be produced directly by fermentation; or 
the fermentation product can be used as starting material 
for subsequent chemical modification (derivatization); or 
thirdly the molecules can be used as lead compounds for 
chemical synthesis. However, the chemical composition of 
bioactive compounds of microbial origin are often highly 
complex, including stereochemical diversities which in 
many instances will make chemical synthesis difficult 
as far as economy is concerned (Lene, 1996). Organic 
compounds from aqua to terrestrial microorganisms have 
extensive past and present use in the treatment of many 
diseases and serve as compounds of interest both in their 
natural form and as templates for synthetic modification. 
These compounds provided important contributions to the 
discovery of antibacterial agents (penicillins, cephalos-
porins, aminoglycosides, tetracyclines, and polyketides), 
immunosuppressive agents (cyclosporins and rapamycin), 
cholesterol-lowering agents (lovastatin and mevastatin), 
antihelmintic agents (ivermectin), antidiabetic agent (acar-
bose) and anti cancer agents (eg, pentostatin, peplomycin, 
and epirubicin) (Butler, 2005; Sneader, 2005).
The search for biologically active small molecules 
produced by soil microbes is conceptually simple. Soil 
samples are collected and microbes are cultured on agar 
plates containing the necessary nutrients. Identification 
of microbial strains having promising biological acti-
vities and purifying the bio-molecules responsible for 
the activities has led to the discovery of many bioactive 
molecules (Friedler, 2004; Marianna et al., 1995). Against 
this background, in the present study, we isolated microbes 
from various habitats and tested their extracts for a range 
of biological activities, in order to obtain valuable com-
pounds for the treatment of diseases, especially cancer.
MATERIALS AND METHODS
All the culture media were purchased from Hi-
Media Laboratories, Mumbai, Fetal Bovine Serum, 
Dulbecco’s Modified Eagle’s Medium (DMEM), MTT, 
Hoechst 33342, Propidium Iodide and Trypsin were pur-
chased from Sigma Aldrich, Germany. Cell Lines such as 
MCF -7 (Human-Breast cancer-epithelial) was purchased 
from the National Centre for Cell Science, Pune, India and 
HeLa (Human-Cervical Cancer-epithelial) was obtained 
from the Indian Institute of Science Bangalore, India.
Sixty different microbial isolates, deposited at the 
Department of Pharmaceutical Biotechnology, MCOPS, 
Manipal, were used for the study. Of these, 36 were bacte-
rial (Coded as B) and 24 were fungal isolates (Coded as F), 
isolated under unusual conditions such as high temperatu-
re, high Sodium Chloride and low glucose concentrations 
(Angel et al., 2009). Extracellular as well as intracellular 
extracts of the metabolites of these isolates were prepared 
as discussed below:
Inoculum development and production of 
metabolites
Nutrient broth was used for bacterial cultures whe-
reas fungal broth containing 1% peptone and 2% dextrose 
was used for fungal cultures. In the case of bacterial cul-
tures, 5 mL of inocula were developed in Nutrient broth 
by incubating at 37 °C for 24 h. Similarly, fungal inocula 
were developed in fungal broth by incubating at 27 °C for 
72-96 h. These were then used to inoculate the production 
media and incubated at 37 °C for 24 to 48 h in case of 
bacterial cultures, and 27 °C for 4-5 days in case of fungal 
cultures, at 150 rpm on a rotary shaker incubator. These 
broths were used for the extraction of extracellular and 
intracellular metabolites.
Extraction of bioactive principles
The culture broth was centrifuged at 3000 rpm for 
15 min to obtain a clear supernatant. Extracellular com-
ponents were extracted successively with solvents such as 
Petroleum ether (P), Ethyl acetate (E) and chloroform (C) 
for extracellular extracts, followed by vacuum evaporation 
of these extracts to obtain the dry extracts.
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The cell sediment obtained on centrifugation of 
the inocula is used to prepare the intracellular extract. 
The cells were redispersed in 5 mL of methanol, probe 
sonicated to release the intracellular components and then 
centrifuged. The methanol in the supernatant was then 
evaporated off and the dried intracellular extract (M) was 
obtained on freeze drying (Kim et al., 2004).
Sample preparation for biological studies
The extracellular and intracellular crude extracts 
were dissolved in 1 mL dimethylsulphoxide (DMSO) and 
transferred to sterile vials. These samples were stored at 
room temperature and protected from light. For cytotoxi-
city studies, the extract volume was fixed in such a way 
that final concentration of DMSO did not exceed 0.1%.
In vitro anticancer activity studies
The extracellular and intracellular extracts prepa-
red were subjected to in vitro cytotoxicity screening on 
HeLa cells by the MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 
5-diphenyltetrazolium bromide) method. The most active 
extracts were further screened on MCF-7 cells by MTT 
assay. Based on the results of in vitro anticancer studies 
of all extracellular and intracellular extracts, two highly 
active extracts were selected for Hoechst 33342 staining 
and cell cycle analysis to study the compound mediated 
apoptosis on HeLa cells.
Determination of mitochondrial synthesis by 
micro culture tetrazolium (MTT) assay
The monolayer cell culture was trypsinized using 
TPVG (Trypsin – Versine – Glucose) and the cell count 
was adjusted to 1.0x105 cells/mL in the medium contai-
ning 10% Fetal bovine serum. Each well of the 96 well 
plates was seeded with 105 cells. After 24 h, when a partial 
monolayer was formed, the supernatant was flicked off 
and 100 µL of (1000 to 31.25 µg/mL) test extracts were 
added to the cells in microtiter plates. The plates were 
incubated at 37 °C for 72 h in a 5% CO2 atmosphere. 
After 72 h, the drug solutions in the wells were discarded 
and 50 µL of MTT (MTT: prepared in Hank’s Balanced 
Salt Solution without phenol red [(HBSS-PR), 2 mg/mL, 
Sigma Chemicals] was added to each well. The plates 
were gently shaken and incubated for 3 h, at 37 °C, in 5% 
CO2 atmosphere. The supernatant was removed, 50 µL of 
1- propanol was added, and the plates were gently shaken 
to solubilize the formed formazan. The absorbance was 
measured using a Microplate reader (ELISA Reader, 
Biotek) at 540 nm (Jeffrey et al., 1998; Rubinstein et al., 
1990; Eisenbrand et al., 2002).
Hoechst 33342 staining for scoring apoptosis
HeLa cell line was maintained in DMEM with 10% 
fetal bovine serum at 37 °C in a CO2
 incubator at 5% 
CO2 atmosphere. The compounds to be screened for their 
potential apoptotic activity were added to the cells in log 
phase at a concentration of their IC50 value, determined 
from cytotoxicity assay. Cells were treated with the com-
pounds under the above-mentioned cell culture conditions 
for a period of 48 h. Cells were monitored under a phase 
contrast microscope at an interval of 12 h till the end of 
the treatment to evaluate compound mediated cell death.
At the end of treatment, cell culture medium was 
removed and cells were washed with 1 X concentration of 
phosphate buffer saline (PBS, pH 7.4). 0.5 mL of trypsin-
EDTA solution was added to the cells and incubated at 
37 °C and 5% CO2 for 3 min. After trypsinisation, cells were 
rounded and detached from the cell culture plate. To this, 
5 mL of DMEM with 10% fetal bovine serum was added, 
and the cell suspension was centrifuged at 1200 rpm for 
4 min at room temperature. The pellet was resuspended in 
the media and cells were counted. Cell count was adjusted 
to 50,000 cells/mL. Cells were washed twice with PBS and 
stained with Hoechst 33342 (2 μg/mL in PBS) for 10 min 
at 37 °C. At the end of staining, cells were centrifuged at 
1200 rpm for 4 min at 4 °C. The pellet was washed with 
PBS twice and spotted on a cover slip. This was observed 
under fluorescent microscope to spot normal cells as well 
as cells showing apoptotic morphology. Doxorubicin was 
used as a positive control for apoptosis in the study. DMSO 
was used as the vehicle control (Yao et al., 2009).
Cell cycle analysis by flow cytometry
Cell cycle analysis was performed by flow cytome-
tric measurements of the DNA content of the cells based 
on propidium iodide staining. For cell cycle analysis, 
HeLa cells were treated with the most active extracellular 
extract of Aspergillus sp. (Coded F-21-E) and doxorubicin 
as positive control at their IC50 value for 48 h. The control, 
comprising cells without any treatment, served as blank. 
DMSO was used as the vehicle control. After treatment, 
cells were trypsinised and washed twice with PBS and 
then fixed with 70% ice cold ethanol in -20 °C overnight. 
After completely removing the alcohol, the cells were spun 
down at 1200 rpm for 5 min and washed with PBS. Cells 
were treated with PBS containing 50 μg/mL of RNase A 
for 3 h at 37 °C, mixed with 25 μg/mL of propidium iodide 
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and analyzed by flow cytometry. Cells in different phases 
of the cell cycle were analyzed for both the controls and 
the cells treated with extracts (Dassonneville et al., 2000; 
Dengler et al., 1995).
Preliminary chemical investigation
Preliminary qualitative chemical analysis of various 
extracts of one promising isolate from each category (one 
bacterial and one fungal) was performed for the identifica-
tion of various constituents of the extracts. All the analyses 
were carried out using 1-2 mL of extract solution. In the 
case of tests for carbohydrates, tests such as Molisch’s, 
Fehling’s, Benedict’s, and Barfoed’s tests were carried 
out. Tests for alkaloids (Dragendroff’s, Mayer’s, and 
Hager’s tests), test for sterols (Liebermann Burchard test 
and Salkowsky test), tests for the detection of phenolic 
compounds and tannins, tests for proteins and free amino 
acids (Biuret test and Ninhydrin test) and also tests for the 
detection of flavonoids, were performed.
Morphological studies and biochemical tests
Morphological studies and biochemical tests of 
selected isolates were performed for partial characteriza-
tion of the isolates and to test for any isolates present in 
repeats. In the case of bacterial isolates, Gram’s Staining 
and Motility Studies (Hanging Drop Method) were carried 
out, while Lactophenol cotton blue staining was used to 
visualize the morphology of the fungal isolates (Tortora, 
2005; Harley, 2002).
Biochemical Tests for selected isolates include Ca-
talase, Indole, Methyl Red and Voges Proskauer (MRVP), 
Citrate Utilization, Urease, Triple Sugar Iron Agar, Carbo-
hydrate Utilization, Starch Utilization, Casein Utilization, 
Gelatin Liquefaction, EMB Agar. Mannitol Salt Agar, and 
SIM Medium tests were carried out (Harley, Prescott, 2002).
RESULTS AND DISCUSSION
In vitro anticancer activity studies
The effect of extracellular and intracellular extracts 
on the viability of cancer cells was determined by MTT 
(3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium 
bromide) assay on HeLa cells. The most active extracts 
were further screened on MCF-7 cells by MTT assay. The 
IC50 doses were determined by exposing cells to various 
concentrations of the drugs (1000 to 10 µg/mL) for 72 h. 
The IC50was defined as the concentration of drug at which 
there was 50% less growth compared to control cells. Each 
experiment was performed in triplicate and is shown in 
the Tables I-III.
Results indicated that the chloroform extract of 
B-2C, ethyl acetate extracts of B-4E, and F-21E identi-
fied as Aspergillus sp. had promising anticancer activity 
against Cervical (HeLa) and Breast cancer (MCF-7) 
cell lines. B-2C at a concentration of 64.67±0.84 µg/mL 
showed 50% less growth compared to control on HeLa 
cells by the MTT method. B-4E showed a value of 
TABLE I - Anticancer activity of bacterial extracts by MTT and 
SRB methods on HeLa cells
Working code IC50±SEM
a 
by MTT method (µg/mL)
B2-P* > 500
B2-C 64.67±0.84
B2-M 427.5±2.16
B4-E 106.82±1.19
B15-E 463.2±2.39
Cisplatin 6.58±0.81
Doxorubicin 1.16±0.33
a Average of three determinations.
* Extracts with IC50 greater than 500 µg/mL not shown
TABLE II - Anticancer activity of fungal extracts by MTT and 
SRB methods on HeLa cells
Working code IC50±SEM
a 
by MTT method (µg/mL)
F6-E 415.11±2.85
F12-M 444.23±2.91
F13-P* > 500
F13-E 421.69±2.17
 F13-M 442.02±1.97
F14-P 198.33±1.82
F14-E 167.68±1.21
F14-C 209.98±2.67
F15-P 192.67±1.73
F15-E 478.53±3.12
F15-C 380.11±2.93
F19-P 247.32±2.18
F19-E 272.17±2.41
F19-C 350.22±2.91
F19-M 287.51±2.68
F21-P 422.39±3.79
F21-E 20.37±0.36
F21-C 383.05±2.73
Cisplatin 6.58±0.81
Doxorubicin 1.16±0.33
a Average of three determinations.
* Extracts with IC50 greater than 500 µg/mL not shown
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TABLE III - Anticancer activity of extracts with promising 
isolates by MTT method on MCF-7 cell lines
Working code IC50±SEM
a 
µg/mL
F21-E 44.75±0.81
B4-E 178.65±1.02
B2-C 197.34±0.94
Cisplatin 10.01±0.46
a Average of three determinations.
106.82±1.19 µg/mL and F-21E showed IC50 of 20.37±0.36 
µg/mL, which were compared with cisplatin with an 
IC50 of 6.58±0.81µg/mL. B-2C at a concentration of 
197.34±0.94 µg/mL showed 50% less growth compared to 
control on MCF-7 cells by the MTT method, B4-E showed 
a value of 178.65±1.02 µg/mL and F-21E showed IC50 of 
44.75±0.81 µg/mL, which were compared with cisplatin 
with an IC50 of 10.01±0.46 µg/mL (Table-III).
Additionally, extracts from other isolates viz., F-
14P, F-14E, F-14C,F-15P and F-19P showed an IC50 of 
125-250 μg/mL and B-2M, B-15E, F-6E, F-12M, F-13C, 
F-13M, F-15E, F-15C, F-19C, F-19E, F-19M, F-21P and 
F-12C showed IC50 between 250-500 μg/mL by MTT on 
HeLa.
Based on the results of in vitro anticancer studies 
of all extracellular and intracellular extracts, two highly 
active extracts were selected for Hoechst 33342 staining to 
study the compound mediated apoptosis. The whole pro-
cess of programmed cell death could be divided into three 
morphological distinct stages. Condensation of chromatin 
of nuclear segments (Karyopyknosis) and their fusion into 
single spherical structures were observed during early 
apoptosis. The second stage zeiosis was characterized by 
progressive blebbing of cytoplasmic membrane and dis-
ruption of phyknotic nucleus into several small spherical 
fragments. In the third stage, the disruption resulted in 
formation of apoptotic bodies. When stained with a nuclear 
fluorochrome Hoechst 33342, the normal (untreated con-
trol) HeLa cells remained uniformly stained with rounded 
and unpunctuated nucleus (Figure 1). HeLa cells treated 
with cisplatin showed nuclear fragmentation, shrinkage of 
cell nucleus, with condensation of the chromatin (karyo-
pyknosis) (Figure 2), which were the characteristic featu-
res of apoptotic morphology. The two extracts selected for 
the study showed some characteristic features of apoptosis. 
Morphological characteristics include nuclear fragmenta-
tion, fragmentation into apoptotic bodies, karyopyknosis 
and zeiosis (membrane blebbing seen frequently in a dying 
cell) (Figures 3 and 4). These observations provide eviden-
FIGURE 1 - Normal (Control) HeLa cells uniformly stained 
with rounded and unpunctuated nucleus showing no signs of 
necrosis or apoptosis.
FIGURE 2 - Effect of cisplatin on HeLa cells, showing: a) 
Nuclear fragmentation; b) Karyopyknosis (shrinkage of a cell 
nucleus, with condensation of the chromatin).
FIGURE 3 - Effect of B-2C on HeLa cells showing: a) Nuclear 
fragmentation; b) Karyopyknosis.
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ce that an anoikis (form of programmed cell death which 
is induced by anchorage-dependent cells detaching from 
the surrounding extracellular matrix) occurred when HeLa 
cells were treated with test extracts selected for the study.
The cell cycle analysis revealed that the proportion 
of cells in the G2/M phase that had been treated with doxo-
rubicin for 48 h was 76.76%. The untreated group yielded 
only 18.65% after 48 h (Figures 5 and 6). This indicated 
that doxorubicin induced cell cycle arrest at the G2/M phase.
As shown in Figure 7, the ethyl acetate extract of F 
21- E (Aspergillus sp) induced an accumulation of cells 
FIGURE 4 - Effect of F-21E on HeLa cells showing: a) Zeiosis 
(membrane blebbing seen frequently in a dying cell) Nuclear 
fragmentation; b) Fragmentation into apoptotic bodies; c) 
Karyopyknosis - shrinkage of a cell nucleus, with condensation 
of the chromatin.
FIGURE 5 - Control HeLa cells showing normal cell cycle.
FIGURE 6 - Doxorubicin showing prominent G2-M phase arrest.
in the Sub-G0 phase (90.92 %) compared to that in the un-
treated cells (1.15 %), indicating that F 21- E extensively 
triggered apoptosis at the dose used (IC50). The chloroform 
extract of B2 showed cell cycle arrest at the Sub G0 phase 
(18.62% versus 1.15% of control). In the S phase, 16.09% 
of cells were found versus 6.34% of control. Also in G2 
–M phase was 28.11% versus 18.65% of control, shown 
in Figure 8.
The chloroform extract of B2 showed increased 
cell population in both the Sub-G0 phase and G2/M phase 
compared to the control cells, indicating that B-2C causes 
both apoptotic and G2/M phase arrest (Figure 8). Entry 
into each phase of the cell-cycle is carefully regulated 
by receptor collectives, termed cell-cycle checkpoints. 
FIGURE 7 - F-21 E treated HeLa cells showing cell accumulation 
in sub G0 phase.
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inactivity of cdc2-B1 and G2-M arrest. Weakened G2/M 
checkpoint under a therapeutic setting may trigger cell 
death via mitotic catastrophe for cells with unrepaira-
ble DNA lesions and mitosis machinery. These results 
suggest that DNA damage in the cells caused by B-2C 
may be irreparable and therefore force the arrested cells 
into apoptosis. Thus, B-2C-induced DNA damage may 
be attributed due to the activation of Chk2 and decline 
in the expression of Cdc25C and Cdc-2, which leads to 
G2/M arrest and eventually, apoptosis.
Preliminary chemical investigation
Chloroform and petroleum ether extract of B-2 indi-
cated the presence of only sterols, while the ethyl acetate 
extract indicated the presence of flavonoids along with 
sterols whereas methanolic intracellular extract showed 
the presence of alkaloids, carbohydrates, phenolic com-
pounds, proteins and amino acids. The anticancer activity 
of B-2 C may be attributed due to the presence of sterols 
(Table IV) (Angel, 2008).
In the case of F-21, the ethyl acetate extract showed 
the presence of only sterols. Hence the anticancer acti-
vity may be due to the presence of sterols. Sterols were 
also found in petroleum ether and chloroform fractions. 
The methanolic extract indicated the presence of various 
chemical constituents viz., carbohydrates, tannins, phe-
nolic compounds, proteins, amino acids and flavonoids 
(Table V).
FIGURE 8 - B-2C treated HeLa cells showing sub G0 (apoptotic) 
and G2-M.arrest.
The G2/M checkpoint prevents DNA-damaged cells from 
entering mitosis and allows for the repair of DNA that 
was damaged in late S or G2 phases prior to mitosis. 
The G2/M checkpoint is controlled by Cdc2/cyclinB. 
Active Cdk1(cdc2) complexed to cyclin B1 is required 
for progression from the G2 to M phase. Regulation of 
the cdc2-B1 complex involves inhibitory phosphates at a 
pair of amino acids in the roof of the active site by Wee1. 
Dephosphorylation of these sites by the phosphatase 
Cdc25C increases Cdk activity. DNA damage activates 
Chk1, which inactivates Cdc25C through phosphoryla-
tion of cdc25C, resulting in the phosphorylation and 
TABLE IV - Qualitative preliminary chemical investigation of various extracts of an active bacterial isolate B-2 (Bacillus sp.)
Nature of Extracts Alkaloids Carbohydrates Sterols
Tannins & 
phenolic 
compounds
Proteins & 
amino acids
Flavonoids
Pet. Ether (B2-P) - - + - - -
Ethylacetate (B2-E) - - + - - +
Chloroform (B2-C) - - + - - -
Methanol (B2-M) + + - + + -
TABLE V - Qualitative preliminary chemical investigation of various extracts of the active fungal isolate F-21 (Aspergillus sp.)
Nature of Extracts Alkaloids Carbohydrates Sterols
Tannins & 
phenolic 
compounds
Proteins & 
amino acids
Flavonoids
Pet. Ether (F21-P) - - + - - -
Ethylacetate (F21-E) - - + - - -
Chloroform (F21-C) - - + - - -
Methanol (F21-M) - + + + + +
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CONCLUSION
Extracellular as well as intracellular extracts of 
the metabolites of thirty-six bacterial and twenty-four 
fungal isolates, grown under unusual conditions such as 
high temperature, high sodium chloride and low glucose 
concentrations, were in vitro tested for their cytotoxic 
potential on various cancer cell lines. The extracts were 
screened on HeLa and MCF-7 cell lines to study cytotoxic 
potential. The crude ethylacetate extract of isolate F-21 
showed promising results by MTT assay with IC50 as low 
as 20.37±0.36 μg/mL on HeLa, and 44.75±0.81 μg/mL on 
MCF-7 cells, comparable with Cisplatin. The isolate F-21 
was identified as Aspergillus sp. Promising results were 
obtained with B-2C and B-4E. Hoechst 33342 staining 
of HeLa cells treated with F-21E and B-2C extracts, in 
comparison with positive and negative controls, revealed 
that cytotoxicity is due to apoptosis as well as cell necrosis. 
Flow-cytometric analysis indicated that the extracts of 
F-21E and B-2C extensively triggered apoptosis, evident 
from the accumulation of cells in the Sub-G0 phase com-
pared to that of control. Further studies can be carried out 
on bioassay-guided fractionation of the active extract for 
the isolation of active constituent, structural elucidation of 
the active constituent, systematic taxonomical studies for 
characterization of the isolates, optimization of production 
parameters, and also on scaling up of the process.
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